Pillstats
Rx only · Injection, Powder, Lyophilized, For Solution · Intravenous

Azithromycin Dihydrate

Brands: Zithromax · Azithromycin Dihydrate

2 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US3 NDCs
2 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
RxCUI (US)18631
US makers2 labelers
Packages3
DEA / ScheduleNone

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

1.2K2.5K3.7K4.9K2025 Q12025 Q22025 Q32025 Q42026 Q1
1.7K
Rx · 2026 Q1
2.5K
Units dispensed
-59%
Rx vs. year ago
5
Quarters · since 2025 Q1

Who makes it2 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
Pfizer Laboratories Div Pfizer Incunknown2SUPPLYING
Slate Run Pharmaceuticals, LLCunknown1SUPPLYING

Regulatory & supply eventsFDA · US

Shortages, recalls, and registration changes attached to this drug concept.

  • Jan 20, 2026
    RESOLVEDShortage resolved: Azithromycin Injection (Pfizer Inc.)

    Azithromycin Injection — reported in shortage by Pfizer Inc.. Therapeutic category: Anti-Infective.

  • Jan 20, 2026
    SHORTAGEDrug shortage: Azithromycin Injection (Pfizer Inc.)

    Azithromycin Injection — reported in shortage by Pfizer Inc.. Therapeutic category: Anti-Infective.

  • Jan 2, 2014
    RECALLRecall (Class III): Zithromax (azithromycin for injection), 500 mg/vial, Sterile, Rx Only, For I.V. infusion only, No latex, No preservativ…

    Failed Impurities/Degradation Specifications: Pfizer is recalling certain lots due to out of specification results for azithromycin N-oxide degradant. — Recalling firm: Pfizer Inc. — Nationwide and Puerto Rico